Author:
Schneider Kari,Ekstrom Joanna,Cafferty Rachel
Abstract
Adolescents, particularly sexual minority youth, account for a disproportionate number of sexually transmitted infections and pelvic inflammatory disease cases. This population is at increased risk of infection and presents unique challenges when it comes to screening and treatment. This chapter will discuss these challenges and suggest some evidence based solutions. Challenges to be discussed include lack of physician comfort in discussing sexual activity with adolescents, issues of confidentiality, difficulties with contacting adolescent patients with their test results, and arranging for treatment of both patients and their partners. A discussion about expedited partner therapy will be included—the legal implications and the role it plays in sexually transmitted infection reduction efforts.
Reference50 articles.
1. Centers for Disease Control and Prevention. Sexually Transmitted Diseases: Adolescents and Young Adults. 7 Dec 2017. Available from: https://www.cdc.gov/std/life-stages-populations/adolescents-youngadults.htm
2. Centers for Disease Control and prevention. Sexually Transmitted Disease Surveillance 2017: Gonorrhea. Available from: https://www.cdc.gov/std/stats17/gonorrhea.htm
3. Sutton MY, Sternberg M, Zaidi A, St Louis ME, Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sexually Transmitted Diseases. 2005;32(12):778-784
4. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sexually Transmitted Diseases. 1992;19(4):185-192
5. Trent M, Chung SE, Forrest L, Ellen JM. Subsequent sexually transmitted infection after outpatient treatment of pelvic inflammatory disease. Archives of Pediatrics & Adolescent Medicine. 2008;162(11):1022-1025